Achaogen Inc·4

Mar 17, 12:10 PM ET

Achaogen Inc 4

4 · Achaogen Inc · Filed Mar 17, 2014

Insider Transaction Report

Form 4
Period: 2014-03-17
Transactions
  • Conversion

    Common Stock

    2014-03-17+800,7291,575,478 total
  • Conversion

    Series C Preferred Stock

    2014-03-17774,7490 total
    Common Stock (774,749 underlying)
  • Conversion

    Series D Preferred Stock

    2014-03-17800,7290 total
    Common Stock (800,729 underlying)
  • Conversion

    Common Stock

    2014-03-17+774,749774,749 total
Footnotes (4)
  • [F1]Each share of Series C and Series D Preferred Stock automatically converted on a 1-to-1 basis into Common Stock immediately prior to the closing of the Issuer's initial public offering on March 17, 2014.
  • [F2]These shares are owned directly by The Wellcome Trust Limited, a ten percent owner of the issuer, as trustee of The Wellcome Trust, and indirectly by The Wellcome Trust.
  • [F3]The shares converted into Common Stock immediately prior to the closing of the Issuer's initial public offering.
  • [F4]The shares do not have an expiration date.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4